CK Life Sciences International (Holdings), Inc. (LSI) Financial Statements
CK Life Sciences International (Holdings), Inc. Financial Overview
CK Life Sciences International (Holdings), Inc.'s market cap is currently $535.66M. The company's EPS TTM is $-0.01; its P/E ratio is -73.13; CK Life Sciences International (Holdings), Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 5.41B | $ 5.52B | $ 5.32B | $ 5.28B | $ 5.40B |
| Gross Profit | $ 785.38M | $ 1.69B | $ 1.64B | $ 1.63B | $ 1.63B |
| Operating Income | $ -135.28M | $ 783.06M | $ 223.85M | $ 219.51M | $ 233.69M |
| EBITDA | $ -49.42M | $ 488.35M | $ 624.75M | $ 598.85M | $ 574.15M |
| Net Income | $ -188.45M | $ -126.55M | $ 17.25M | $ 131.96M | $ 162.80M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 603.07M | $ 571.21M | $ 676.16M | $ 704.13M | $ 902.47M |
| Total Assets | $ 11.84B | $ 10.79B | $ 11.25B | $ 11.27B | $ 11.73B |
| Total Debt | $ 6.62B | $ 6.10B | $ 5.93B | $ 5.95B | $ 6.21B |
| Net Debt | $ 6.02B | $ 5.55B | $ 5.27B | $ 5.25B | $ 5.32B |
| Total Liabilities | $ 7.99B | $ 7.28B | $ 7.06B | $ 7.11B | $ 7.23B |
| Stockholders' Equity | $ 3.78B | $ 3.51B | $ 4.19B | $ 4.16B | $ 4.50B |
| Cash Flow | |||||
| Free Cash Flow | $ -277.76M | $ 157.00M | $ 222.35M | $ 146.69M | $ 206.33M |
| Operating Cash Flow | $ -32.77M | $ 353.53M | $ 514.18M | $ 363.66M | $ 423.57M |
| Investing Cash Flow | $ -362.68M | $ -96.64M | $ -67.96M | $ -22.12M | $ -257.88M |
| Financing Cash Flow | $ 428.57M | $ -341.98M | $ -477.95M | $ -515.34M | $ -220.08M |
Currency in HKD